StonvexLoading…
StonvexStonvexStonvexCore line items from TPCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $34.03M | $31.59M | $31.43M | $22.28M |
Operating Income | $-2.16M | $-4.63M | $-1.11M | $-1.56M |
Net Income | $-2.75M | $-7.04M | $-979.01K | $-349.83K |
EPS (Diluted) | $-0.29 | $-0.81 | $-0.11 | $-0.04 |
Total Assets | $33.53M | $34.75M | $36.21M | $37.85M |
Total Liabilities | $24.79M | $26.94M | $21.61M | $22.59M |
Cash & Equivalents | $195.00K | $138.00K | $534.47K | $1.05M |
Free Cash Flow OCF − CapEx | $-4.72M | $-2.50M | $812.54K | $-681.16K |
Shares Outstanding | 9.75M | 8.78M | 8.61M | 8.58M |